Portal Diabetes, Inc.
PrivateLast Round
Grant
Sep 24, 2024
Total Funding Raised
$2.65M
Company Overview
Portal Diabetes, Inc. is a medical technology company developing a fully automated, implantable insulin pump system designed to function as an artificial pancreas for patients with type 1 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Portal Diabetes, Inc. Comparables
Compare Portal Diabetes, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beta Bionics | 72% | |
| Sequel Med Tech | 70% | |
| Medtronic | 70% | |
Portal Diabetes, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2024 | ||||
| VC Round | Dec 5, 2019 | ||||
| Grant | Jun 1, 2017 |
Key People
Founding team and executive leadership
Portal Diabetes, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Indiana Economic Development Corporation | Grant |
| JDRF | Grant |
Portal Diabetes, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Portal Diabetes, Inc.'s valuation, stock price, and market status.